title: Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria.
abstract: Optimal treatment for patients suffering from gastrointestinal stromal tumors (GIST) is based on an interdisciplinary treatment approach. Austrian representatives of Medical and Surgical Oncology, Pathology, Radiology, Nuclear Medicine, Gastroenterology, and Laboratory Medicine issued this manuscript on a consensual base within the context of currently available and published literature. This paper contains guidelines and recommendations for diagnosis, therapy, and follow-up of GIST patients in Austria.
authors.affiliation: Department of Surgery, General Hospital, Wiener Neustadt, Vienna, Austria. evelyne.bareck@wienerneustadt.lknoe.at
authors.forename: Evelyne
authors.initials: E
authors.lastname: Bareck
authors.forename: Ahmed
authors.initials: A
authors.lastname: Ba-Ssalamah
authors.forename: Thomas
authors.initials: T
authors.lastname: Brodowicz
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Eisterer
authors.forename: Michael
authors.initials: M
authors.lastname: Häfner
authors.forename: Christoph
authors.initials: C
authors.lastname: Högenauer
authors.forename: Ulrike
authors.initials: U
authors.lastname: Kastner
authors.forename: Thomas
authors.initials: T
authors.lastname: Kühr
authors.forename: Friedrich
authors.initials: F
authors.lastname: Längle
authors.forename: Bernadette
authors.initials: B
authors.lastname: Liegl-Atzwanger
authors.forename: Sebastian F
authors.initials: SF
authors.lastname: Schoppmann
authors.forename: Gerlig
authors.initials: G
authors.lastname: Widmann
authors.forename: Fritz
authors.initials: F
authors.lastname: Wrba
authors.forename: Johannes
authors.initials: J
authors.lastname: Zacherl
authors.forename: Ferdinand
authors.initials: F
authors.lastname: Ploner
mesh_terms: D000328:Adult; D000359:Aftercare; D001317:Austria; D001549:Benzamides / Q000627:therapeutic use; D001706:Biopsy; D002648:Child; D003131:Combined Modality Therapy; D003299:Cooperative Behavior; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D018450:Disease Progression; D016099:Endoscopy, Gastrointestinal; D005500:Follow-Up Studies; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000601:surgery*; D046152:Gastrointestinal Stromal Tumors / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000601:surgery*; D041981:Gastrointestinal Tract / Q000473:pathology / Q000601:surgery; D006801:Humans; D000068877:Imatinib Mesylate; D007211:Indoles / Q000627:therapeutic use; D033183:Interdisciplinary Communication; D008940:Mitotic Index; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000235:genetics / Q000473:pathology / Q000601:surgery; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D049451:Nomograms; D010166:Palliative Care; D010671:Phenylurea Compounds / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D019009:Proto-Oncogene Proteins c-kit / Q000235:genetics; D011725:Pyridines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D000077210:Sunitinib
chemical_list: D001549:Benzamides; D007211:Indoles; D010671:Phenylurea Compounds; D010879:Piperazines; D011725:Pyridines; D011743:Pyrimidines; D011758:Pyrroles; C559147:regorafenib; D000068877:Imatinib Mesylate; D019009:Proto-Oncogene Proteins c-kit; D000077210:Sunitinib